KLF9 and endometrial cancer: KLF9 is a repressor of estrogen receptor α actions on select nuclear target genes in Ishikawa endometrial cancer cells and this ability may contribute to aberrant cell growth responses in the face of ovarian estrogen stimulation, when KLF9 expression is lowered or absent [185,186].